# Loar Holdings Inc.: financial statements, quarterly

LOAR · NYSE · CIK 2000178 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/loar.md) · [Financials](/companies/loar/financials.md) · [Filings](/companies/loar/filings.md) · [Insiders](/companies/loar/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/loar/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [82.8](/filings/0000950170-24-126401.md) | [86.4 d](/filings/0002000178-26-000003.md) | [91.8](/filings/0000950170-25-069849.md) | [97.0](/filings/0000950170-25-107644.md) | [104](/filings/0001193125-25-276199.md) | [110 d](/filings/0002000178-26-000003.md) | [115](/filings/0001193125-26-210585.md) | [123](/filings/0001193125-26-336945.md) | [127](/filings/0001193125-25-276199.md) | [132 d](/filings/0002000178-26-000003.md) | [156](/filings/0001193125-26-210585.md) | [172](/filings/0001193125-26-336945.md) |
| Cost of revenue | $m | [42.2](/filings/0000950170-24-126401.md) | [46.3 d](/filings/0002000178-26-000003.md) | [47.4](/filings/0000950170-25-069849.md) | [49.5](/filings/0000950170-25-107644.md) | [50.6](/filings/0001193125-25-276199.md) | [56.5 d](/filings/0002000178-26-000003.md) | [55.0](/filings/0001193125-26-210585.md) | [56.9](/filings/0001193125-26-336945.md) | [60.0](/filings/0001193125-25-276199.md) | [63.1 d](/filings/0002000178-26-000003.md) | [76.8](/filings/0001193125-26-210585.md) | [80.4](/filings/0001193125-26-336945.md) |
| Gross profit | $m | [40.6](/filings/0000950170-24-126401.md) | [40.1 d](/filings/0002000178-26-000003.md) | [44.4](/filings/0000950170-25-069849.md) | [47.5](/filings/0000950170-25-107644.md) | [52.9](/filings/0001193125-25-276199.md) | [54.0 d](/filings/0002000178-26-000003.md) | [59.7](/filings/0001193125-26-210585.md) | [66.2](/filings/0001193125-26-336945.md) | [66.8](/filings/0001193125-25-276199.md) | [68.6 d](/filings/0002000178-26-000003.md) | [79.2](/filings/0001193125-26-210585.md) | [91.2](/filings/0001193125-26-336945.md) |
| Selling, general and administrative | $m | [21.9](/filings/0000950170-24-126401.md) | [21.9 d](/filings/0002000178-26-000003.md) | [22.9](/filings/0000950170-25-069849.md) | [27.3](/filings/0000950170-25-107644.md) | [30.2](/filings/0001193125-25-276199.md) | [31.9 d](/filings/0002000178-26-000003.md) | [33.1](/filings/0001193125-26-210585.md) | [36.9](/filings/0001193125-26-336945.md) | [35.8](/filings/0001193125-25-276199.md) | [37.9 d](/filings/0002000178-26-000003.md) | [44.5](/filings/0001193125-26-210585.md) | [46.5](/filings/0001193125-26-336945.md) |
| Operating income | $m | [17.1](/filings/0000950170-24-126401.md) | [17.7 d](/filings/0002000178-26-000003.md) | [21.4](/filings/0000950170-25-069849.md) | [22.2](/filings/0000950170-25-107644.md) | [22.8](/filings/0001193125-25-276199.md) | [21.2 d](/filings/0002000178-26-000003.md) | [26.1](/filings/0001193125-26-210585.md) | [27.3](/filings/0001193125-26-336945.md) | [29.0](/filings/0001193125-25-276199.md) | [23.8 d](/filings/0002000178-26-000003.md) | [33.5](/filings/0001193125-26-210585.md) | [41.9](/filings/0001193125-26-336945.md) |
| Interest expense | $m | [17.2](/filings/0000950170-24-126401.md) | [17.9 d](/filings/0002000178-26-000003.md) | [17.7](/filings/0000950170-25-069849.md) | [10.6](/filings/0000950170-25-107644.md) | [10.0](/filings/0001193125-25-276199.md) | [13.8 d](/filings/0002000178-26-000003.md) | [6.5](/filings/0001193125-26-210585.md) | [6.5](/filings/0001193125-26-336945.md) | [6.0](/filings/0001193125-25-276199.md) | [6.7 d](/filings/0002000178-26-000003.md) | [18.7](/filings/0001193125-26-210585.md) | [20.0](/filings/0001193125-26-336945.md) |
| Income tax | $m | [(2.9)](/filings/0000950170-24-126401.md) | [0.4 d](/filings/0002000178-26-000003.md) | [1.4](/filings/0000950170-25-069849.md) | [2.3](/filings/0000950170-25-107644.md) | [4.2](/filings/0001193125-25-276199.md) | [(1.0) d](/filings/0002000178-26-000003.md) | [4.4](/filings/0001193125-26-210585.md) | [4.1](/filings/0001193125-26-336945.md) | [(4.6)](/filings/0001193125-25-276199.md) | [4.5 d](/filings/0002000178-26-000003.md) | [3.7](/filings/0001193125-26-210585.md) | [5.1](/filings/0001193125-26-336945.md) |
| Net income | $m | [2.9](/filings/0000950170-24-126401.md) | [(0.6) d](/filings/0002000178-26-000003.md) | [2.2](/filings/0001193125-25-276199.md) | [7.6](/filings/0001193125-25-276199.md) | [8.7](/filings/0001193125-25-276199.md) | [3.7 d](/filings/0002000178-26-000003.md) | [15.3](/filings/0001193125-26-336945.md) | [16.7](/filings/0001193125-26-336945.md) | [27.6](/filings/0001193125-25-276199.md) | [12.5 d](/filings/0002000178-26-000003.md) | [11.1](/filings/0001193125-26-336945.md) | [16.7](/filings/0001193125-26-336945.md) |
| Diluted EPS | $ per share | [14000.14](/filings/0000950170-24-126401.md) | not reported | [11023.54](/filings/0000950170-25-069849.md) | [0.09](/filings/0000950170-25-107644.md) | [0.09](/filings/0001193125-25-276199.md) | not reported | [0.16](/filings/0001193125-26-210585.md) | [0.17](/filings/0001193125-26-336945.md) | [0.29](/filings/0001193125-25-276199.md) | not reported | [0.12](/filings/0001193125-26-210585.md) | [0.18](/filings/0001193125-26-336945.md) |
| Basic EPS | $ per share | [14000.14](/filings/0000950170-24-126401.md) | not reported | [11023.54](/filings/0000950170-25-069849.md) | [0.09](/filings/0000950170-25-107644.md) | [0.10](/filings/0001193125-25-276199.md) | not reported | [0.16](/filings/0001193125-26-210585.md) | [0.18](/filings/0001193125-26-336945.md) | [0.29](/filings/0001193125-25-276199.md) | not reported | [0.12](/filings/0001193125-26-210585.md) | [0.18](/filings/0001193125-26-336945.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [21.5](/filings/0000950170-25-047242.md) | [28.2](/filings/0000950170-24-059554.md) | [73.2](/filings/0000950170-24-096339.md) | [55.2](/filings/0000950170-24-126401.md) | [54.1](/filings/0002000178-26-000003.md) | [80.5](/filings/0000950170-25-069849.md) | [103](/filings/0000950170-25-107644.md) | [99.0](/filings/0001193125-25-276199.md) | [84.8](/filings/0001193125-26-336945.md) | [94.9](/filings/0001193125-26-210585.md) | [122](/filings/0001193125-26-336945.md) |
| Current assets | $m | not reported | [171](/filings/0000950170-25-047242.md) | [182](/filings/0000950170-24-059554.md) | [234](/filings/0000950170-24-096339.md) | [232](/filings/0000950170-24-126401.md) | [221](/filings/0002000178-26-000003.md) | [258](/filings/0000950170-25-069849.md) | [286](/filings/0000950170-25-107644.md) | [295](/filings/0001193125-25-276199.md) | [298](/filings/0001193125-26-336945.md) | [335](/filings/0001193125-26-210585.md) | [375](/filings/0001193125-26-336945.md) |
| Total assets | $m | not reported | [1,050](/filings/0000950170-25-047242.md) | [1,054](/filings/0000950170-24-059554.md) | [1,100](/filings/0000950170-24-096339.md) | [1,472](/filings/0000950170-24-126401.md) | [1,451](/filings/0002000178-26-000003.md) | [1,479](/filings/0000950170-25-069849.md) | [1,498](/filings/0000950170-25-107644.md) | [1,534](/filings/0001193125-25-276199.md) | [2,030](/filings/0001193125-26-336945.md) | [2,298](/filings/0001193125-26-210585.md) | [2,326](/filings/0001193125-26-336945.md) |
| Current liabilities | $m | not reported | [51.5](/filings/0000950170-25-047242.md) | [58.8](/filings/0000950170-24-059554.md) | [48.0](/filings/0000950170-24-096339.md) | [58.7](/filings/0000950170-24-126401.md) | [41.8](/filings/0002000178-26-000003.md) | [50.3](/filings/0000950170-25-069849.md) | [46.5](/filings/0000950170-25-107644.md) | [49.9](/filings/0001193125-25-276199.md) | [63.5](/filings/0001193125-26-336945.md) | [73.5](/filings/0001193125-26-210585.md) | [76.5](/filings/0001193125-26-336945.md) |
| Total liabilities | $m | not reported | [632](/filings/0000950170-25-047242.md) | not reported | not reported | [702](/filings/0000950170-24-126401.md) | [362](/filings/0002000178-26-000003.md) | [372](/filings/0000950170-25-069849.md) | [369](/filings/0000950170-25-107644.md) | [374](/filings/0001193125-25-276199.md) | [855](/filings/0001193125-26-336945.md) | [1,118](/filings/0001193125-26-210585.md) | [1,127](/filings/0001193125-26-336945.md) |
| Long-term debt | $m | not reported | [529](/filings/0000950170-25-047242.md) | [527](/filings/0000950170-24-059554.md) | [248](/filings/0000950170-24-096339.md) | [596](/filings/0000950170-24-126401.md) | [277](/filings/0002000178-26-000003.md) | [277](/filings/0000950170-25-069849.md) | [278](/filings/0000950170-25-107644.md) | [279](/filings/0001193125-25-276199.md) | [711](/filings/0001193125-26-336945.md) | [943](/filings/0001193125-26-210585.md) | [943](/filings/0001193125-26-336945.md) |
| Current portion of debt | $m | not reported | [6.9](/filings/0000950170-25-047242.md) | [6.9](/filings/0000950170-24-059554.md) | [2.5](/filings/0000950170-24-096339.md) | [6.0](/filings/0000950170-24-126401.md) | [0.0](/filings/0002000178-26-000003.md) | [0.0](/filings/0000950170-25-069849.md) | [0.0](/filings/0000950170-25-107644.md) | [0.0](/filings/0001193125-25-276199.md) | [4.4](/filings/0001193125-26-336945.md) | [6.7](/filings/0001193125-26-210585.md) | [6.7](/filings/0001193125-26-336945.md) |
| Shareholders' equity | $m | [419](/filings/0000950170-24-126401.md) | [418](/filings/0000950170-25-047242.md) | [421](/filings/0000950170-24-059554.md) | [758](/filings/0000950170-24-096339.md) | [770](/filings/0000950170-24-126401.md) | [1,089](/filings/0002000178-26-000003.md) | [1,107](/filings/0000950170-25-069849.md) | [1,129](/filings/0000950170-25-107644.md) | [1,160](/filings/0001193125-25-276199.md) | [1,175](/filings/0001193125-26-336945.md) | [1,180](/filings/0001193125-26-210585.md) | [1,199](/filings/0001193125-26-336945.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.4 d](/filings/0000950170-24-126401.md) | [12.0 d](/filings/0002000178-26-000003.md) | [10.8](/filings/0000950170-25-069849.md) | [7.1 d](/filings/0000950170-25-107644.md) | [16.3 d](/filings/0001193125-25-276199.md) | [20.7 d](/filings/0002000178-26-000003.md) | [28.4](/filings/0001193125-26-210585.md) | [23.8 d](/filings/0001193125-26-336945.md) | [29.7 d](/filings/0001193125-25-276199.md) | [30.4 d](/filings/0002000178-26-000003.md) | [30.9](/filings/0001193125-26-210585.md) | [30.3 d](/filings/0001193125-26-336945.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | period not labelled (2023-03-31) | period not labelled (2023-06-30) | period not labelled (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [0.2](/filings/0000950170-24-059554.md) | [0.2](/filings/0000950170-24-096339.md) | [0.2](/filings/0000950170-24-126401.md) | [0.2](/filings/0000950170-25-069849.md) | [89.2](/filings/0000950170-25-107644.md) | [91.9](/filings/0001193125-25-276199.md) | [95.8](/filings/0001193125-26-210585.md) | [96.1](/filings/0001193125-26-336945.md) | [95.9](/filings/0001193125-25-276199.md) | [95.7](/filings/0001193125-26-210585.md) | [95.5](/filings/0001193125-26-336945.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 93,688,471 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-336945.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.